UNC Institute for Global Health & Infectious Diseases
Strategic Alliance Partnership
Advancing the profession, navigating physicians through an evolving healthcare system
Latest from UNC Institute for Global Health & Infectious Diseases
Technology's Role in the Future of AIDS Care
The fight against the acquired immunodeficiency syndrome (AIDS) epidemic has made huge strides in recent years, but there is still much more work to be done. What role technology will play in that effort has yet to be determined.
Reaching at Risk Patients in AIDS Care and Prevention
There are several areas of the country where the acquired immunodeficiency syndrome (AIDS) epidemic remains to be a problem. Both minorities and those in the southern states are seeing a continued problem with the disease, while the northern states are seeing improvements in numbers.
NIH-Funded Project Looks at Ways to Use Technology in AIDS Prevention and Care
As the battle against the acquired immunodeficiency syndrome (AIDS_ epidemic continues, a project funded by the National Institutes of Health (NIH) is looking at different ways to use technology to help in the prevention and care of the human immunodeficiency virus (HIV) and AIDS.
Major Gaps in HIV Research Leave Pregnant Women at Risk
Although prenatal human immunodeficiency virus (HIV) transmission has declined by 90% since the early 1990s, the need for studies focusing are pregnant women with HIV are very much needed.
Potential HIV Medication Protects Mother-to-Child Transmission
Untreated pregnant women with the human immunodeficiency virus (HIV) will transmit the infection to their child up to 45% of the time. But a new anti-HIV medication could lower that percentage.
The HIV Target That We're Not Talking About
Researchers from the University of North Carolina (UNC) analyzed how the human immunodeficiency virus (HIV) attacks macrophages – a target that, up until now, was believed to have little to do with infection.
Long-Acting Raltegravir Prevents Vaginal HIV Transmission
Pre-clinical study results appear to demonstrate the efficacy of a new long-acting formulation of the HIV medication raltegravir in preventing vaginal transmission of HIV in animal models.
Jenna Honeycutt from the University of North Carolina: Learning From Macrophages to Help Fight HIV
If research continues focusing on macrophages and their role in the human immunodeficiency virus (HIV), it could mean new opportunities to treat patients and eventually help find a cure.
Jenna Honeycutt from the University of North Carolina: Study Contradicts Prior Views of Macrophages in HIV
In previous studies it had been shown that macrophages were not targeted by HIV when looking at how the virus develops. New research of mouse models has shown evidence that that may not be the case.
Tweets by @uncglobalhealth
Affordable Care Act
PHYSICIAN'S MONEY DIGEST >
Affiliated Websites >
American Journal of Managed Care
Cure Hepatitis C
Specialty Pharmacy Times
Rare Disease Report
MD Magazine Resources
Terms & Conditions
Copyright MD Magazine 2006-2017 Intellisphere, LLC. All Rights Reserved.